NEW YORK (GenomeWeb News) — Seoul, South Korea-based Interface Engineering will sell and service Eksigent’s NanoLC and ExpressLC high-performance liquid-chromatography systems in Korea, Eksigent said today.
Interface Engineering is a division of Bio-Medical Science Co., a group of Korean distribution and life-science technology companies.
Financial terms of the agreement were not released.